Ostarine (MK-2866)
SARM (MK-2866 / Enobosarm)
Also known as MK-2866, MK2866, osta, ostarine, enobosarm
Half-life
~24 hours
What is Ostarine (MK-2866)?
The mildest and most studied SARM. Selective androgen receptor modulator with relatively lower suppression.
How Ostarine (MK-2866) works
Selectively activates androgen receptors in muscle and bone with reduced prostate activity versus testosterone.
Benefits & uses
- Lean muscle gain
- Muscle preservation in a deficit (cutting)
- Milder/less suppressive than other SARMs
- Bone/joint support (studied for cachexia)
- Lean muscle
- Muscle preservation (cutting)
- Milder SARM
Common uses: Muscle preservation, recomposition, recovery, mild strength/mass gains.
Ostarine (MK-2866) dosage
Protokol doesn't recommend doses for prescription or controlled compounds. Any figures below are reference or observational reports — dosing should be set with a qualified clinician.
- Commonly reported
- Observational: ~10–25 mg/day, 6–10 week runsObservational use reports — not a recommendation.
Ostarine (MK-2866) half-life
~24 hours
Ostarine (MK-2866) side effects
Mild suppression, lipid changes, occasional liver enzyme elevation.
- Mild testosterone suppression
- HDL reduction
- Mild liver enzyme elevation
- Testosterone suppression (dose/duration-dependent)
- Possible gyno in some
- Lipid shift (HDL)
- Lethargy
- Testosterone suppression
- Lipid shift
- Possible gyno
Warnings & monitoring
- Requires bloodwork (testosterone, lipids) + medical guidance
- Still suppresses — longer/higher runs need PCT
- FDA-warned / WADA-banned / gray-market purity unreliable
- Not approved for human use
- Requires bloodwork + medical guidance
- Suppressive at higher/longer doses — PCT
- FDA-warned / WADA-banned / gray-market
Preparation & storage
- Storage
- Room temperature, dry storage.
Ostarine (MK-2866) interactions
with GW501516
Caution · moderateOstarine is relatively mild; GW501516 is a PPARδ agonist associated with carcinogenicity in animal studies. Human risk unknown but significant enough to warrant caution.
Timing: GW501516 (Cardarine) has been discontinued in research due to cancer findings in animal studies
with LGD-4033
Caution · mildCombining two SARMs increases suppression beyond either alone. Ostarine is milder than LGD — this stack is more manageable than RAD+LGD but still requires bloodwork monitoring and PCT consideration.
Timing: Use Ostarine 10–15 mg with LGD 5 mg; monitor testosterone levels
with Cardarine
CompatibleA popular mild body recomposition stack. Ostarine preserves muscle during a cut while Cardarine boosts fat oxidation and endurance. Minimal androgenic side effects at these doses.
Timing: Daily; Cardarine 20 mg, Ostarine 10–25 mg
with Cardarine
CompatibleCardarine boosts endurance and fat oxidation while Ostarine preserves lean mass on a deficit — a well-studied recomp stack.
Timing: Both daily during recomp/cut cycles, 8–12 weeks
with Enclomiphene
CompatibleMild SARM suppression can be supported with low-dose enclomiphene without crashing E2 like Clomid sometimes does.
Timing: Enclomiphene 12.5mg daily during/after Ostarine to support LH
with MK-677
CompatibleA popular entry-level recomp stack. Ostarine preserves lean mass and strength while MK-677 boosts GH/IGF-1. Minimal suppression from Ostarine at low doses.
Timing: Both can be run concurrently; MK-677 year-round, Ostarine 8–12 week cycles
with MK-677
CompatibleMK-677 elevates GH/IGF-1 while Ostarine activates androgen receptors selectively — a steady, non-suppressive lean-gain stack.
Timing: MK-677 nightly, Ostarine morning, 12–16 weeks
with S4 (Andarine)
Compatible · lowS4 (Andarine) stacks well with Ostarine for cutting or recomposition. S4 provides anabolic hardening effects; Ostarine preserves muscle in a deficit. Vision side effects from S4 are dose-dependent.
Timing: Run concurrently; S4 may cause visual disturbances at higher doses
Commonly stacked with
More SARM
- ACP-105Investigational nonsteroidal SARM studied for anabolic selectivity.
- Andarine (S4)Dry SARM with significant strength and hardening effects. Known for vision…
- LGD-3303Investigational oral SARM with anabolic intent in muscle and bone.
- Ligandrol (LGD-4033)Potent oral SARM with strong lean-mass and strength effects.
- S-23High-potency investigational SARM with strong suppressive activity.
- Testolone (RAD-140)High-potency SARM with pronounced strength and lean-mass effects.
